{
    "N/R/U": "N",
    "Applicant": "CELLTRION, Inc.",
    "BLA Number": "761399",
    "Proprietary Name": "Omlyclo",
    "Proper Name": "omalizumab-igec",
    "BLA Type": "351(k) Interchangeable",
    "Strength": "75MG/0.5ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Pre-Filled Syringe",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "7-Mar-25",
    "Ref. Product Proper Name": "omalizumab",
    "Ref. Product Proprietary Name": "Xolair",
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "1996",
    "Product Number": "1",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": "Date TBD",
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}